Raleigh, NC, United States of America

Leone E Kirk, Iii

This inventor holds 1 USPTO granted patent. Top assignee: Burroughs Wellcome Co.. Active years: 1992.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Leone E Kirk, Iii. Retrieved from https://idiyas.com/inventor/leone-e-kirk-iii

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 1992

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Leone E. Kirk, III: Innovator in Medical Treatment

Introduction

Leone E. Kirk, III is a notable inventor based in Raleigh, North Carolina. He has made significant contributions to the field of medicine, particularly in the treatment of idiopathic thrombocytopaenic purpura. His innovative approach has garnered attention in the medical community.

Latest Patents

Kirk holds a patent for a method of treating idiopathic thrombocytopaenia purpura using 2',3'-dideoxy-3'-azidonucleosides, specifically 3'-azido-3'-deoxythymidine. This patent represents a crucial advancement in therapeutic options for patients suffering from this condition.

Career Highlights

Throughout his career, Kirk has been associated with Burroughs Wellcome Co., where he has worked on various medical innovations. His dedication to improving patient outcomes is evident in his research and development efforts.

Collaborations

Kirk has collaborated with esteemed colleagues, including Dannie H. King and Richard H. Clemons. These partnerships have contributed to the advancement of medical treatments and innovations.

Conclusion

Leone E. Kirk, III is a distinguished inventor whose work in medical treatment has made a lasting impact. His patent for treating idiopathic thrombocytopaenic purpura showcases his commitment to advancing healthcare solutions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…